Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH antagonist versus co-flare protocol in first IVF cycle for women with low ovarian reserve
2012-004824-39Phase 4Completed
- Sponsor
- University Hospitals of Leicester NHS Trust
- Start
- Jun 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of cetrorelix and buserelin in Diminished Ovarian Reserve (DOR) and infertility (2 arms), sponsored by University Hospitals of Leicester NHS Trust. Primary endpoint: Number of oocytes retrieved. Started Jun 2014; status: completed.
02
Drugs
cetrorelixbuserelin
03
Conditions
Diminished Ovarian Reserve (DOR)infertility
Beyond the preview
Go deeper on 2012-004824-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004824-39.